Genetic variant of IL28B rs12979860, as predictive marker of interferon‐based therapy in Pakistani population

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0463|123|4|342-349

ISSN： 0903-4641

Source： APMIS (ELECTRONIC), Vol.123, Iss.4, 2015-04, pp. : 342-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon‐based therapy in chronic hepatitis C

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 6, 2015-06 ,pp. : 1075-1084 (10)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin‐ 28B: a prognostic marker in interferon based therapy of chronic HCV patients of the Pakistan with variable treatment response

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 9, 2015-09 ,pp. : 765-771 (7)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Naturally occurring, resistance‐associated hepatitis C virus NS5A variants are linked to interleukin‐28B genotype and are sensitive to interferon‐based therapy

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E115-E121 (NaN)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon lambda 4 variant rs12979860 is not associated with RAV NS5A Y93H in hepatitis C virus genotype 3a

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1377-1378 (2)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Amino Acid Substitution in HCV Core/NS5A Region and Genetic Variation Near IL28B Gene Affect Treatment Efficacy to Interferon plus Ribavirin Combination Therapy

By  

Intervirology, Vol. 55, Iss. 3, 2011-07 ,pp. : 231-241 (11)

Karger

Access to resources Recommend Favorite